CHRISTOPHER PATUSKY - 03 Jan 2023 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
03 Jan 2023
Net transactions value
-$370,580
Form type
4
Filing time
04 Jan 2023, 15:30:14 UTC
Previous filing
18 Nov 2022
Next filing
16 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $176,060 +2,000 +119% $88.03 3,680 03 Jan 2023 Direct F1
transaction UTHR Common Stock Disposed to Issuer $546,640 -2,000 -54% $273.32 1,680 03 Jan 2023 Direct F1
holding UTHR Common Stock 1,100 03 Jan 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 +2,000 +33% $0.000000 8,000 03 Jan 2023 Common Stock 2,000 $88.03 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
F2 Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.